Literature DB >> 11464195

Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a.

R Anadolu1, T Oskay, C Erdem, A Boyvat, E Terzi, E Gürgey.   

Abstract

Epidermodysplasia verruciformis (EV) is an autosomal recessive disease characterized by the lifelong eruption of disseminated verrucae-like lesions. Numerous treatment modalities have been used to treat EV without benefit. Recently, retinoid and interferon therapies have been found to be of value in the treatment of EV. We present a case of EV that was treated with a combination of acitretin and interferon alfa-2a.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11464195     DOI: 10.1067/mjd.2001.114575

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

Review 1.  An armamentarium of wart treatments.

Authors:  Michelle M Lipke
Journal:  Clin Med Res       Date:  2006-12

2.  Epidermodysplasia verruciformis: An early and unusual presentation.

Authors:  Ilteris Murat Emsen; M Esref Kabalar
Journal:  Can J Plast Surg       Date:  2010

Review 3.  Warts and all: human papillomavirus in primary immunodeficiencies.

Authors:  Jennifer W Leiding; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2012-10-01       Impact factor: 10.793

4.  Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation.

Authors:  David F McDermott; Bryan Gammon; Peter J Snijders; Ihunanya Mbata; Beth Phifer; A Howland Hartley; Chyi-Chia Richard Lee; Philip M Murphy; Sam T Hwang
Journal:  Pediatr Dermatol       Date:  2009 May-Jun       Impact factor: 1.588

5.  Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report.

Authors:  Rui Yoshida; Toshihiko Kato; Masahiko Kawase; Mariko Honda; Tsuyoshi Mitsuishi
Journal:  BMC Dermatol       Date:  2014-07-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.